TSN Media Group Announces the Immediate Availability of Proximity Health Solutions
Stamford, CT - TSN Media Group announces the immediate availability of Proximity Health Solutions (PHS). Leveraging 20+ years of grass roots marketing experience, access to 20,000 local venues and community thought leaders, Proximity Health Solutions (PHS) conducts all recruiting, educational events and pre-screening within proximity of each client-designated investigator site.
Proximity Health Solutions provides a unique service, addressing the biggest gaps in clinical trials: attracting, educating and enrolling qualified, engaged, and diverse participants.
“We’ve seen clinical trial outcomes continue to be marginalized as a result of recruitment not meeting objectives, subjects not in proximity to investigator sites, and participants unaware of study expectations,” says Vera Rulon MS, RHIT, FAHIMA, PHS’s Chief Content Officer. “At Proximity Health Solutions we apply a unique approach that converges local influencers and thought leaders with local investigators to build relationships with patients. We meet patients where they are, engage them in settings where they feel comfortable and educate them about a specific local clinical trial in which to enroll.”
PHS will support research and development teams at pharmaceutical and biotechnology manufacturers that sponsor clinical trials for new drug development, government organizations looking to educate citizens about public health issues and healthcare options, as well as clinical trial research organizations that conduct clinical trials.
About Proximity Health Solutions
Proximity Health Solutions (PHS) is a newly formed division of TSN Media Group. PHS works with clinical trial sponsors and contract research organizations (CROs) to understand their recruitment goals and align on a strategy. PHS formulates individualized, grass roots recruitment plans which utilize local influencers, thought leaders, community venues and local media to engage and recruit qualified patients within proximity of client designated clinical trial investigator sites. On-line and live educational events are conducted to educate potential enrollees about medical conditions and specific details of each clinical trial study. Local investigator site personnel are encouraged to participate in educational events to begin to establish a relationship with patients. Patient prescreening is conducted during recruitment process and at conclusion of each educational event.
About TSN Media Group
Founded in 1991, TSN Media Group is a health and wellness marketing and media services company focusing on products and services for the mature consumer. The company provides clients reach and access to this mature consumer audience utilizing a combination of traditional, digital and online media.
TSN has executed more than 500 individual brand assignments in 38 healthcare categories, representing a prestigious client base that includes major healthcare companies, pharmaceutical companies, government agencies and clinical research organizations (CRO).
For More Information Please Contact:
Jeff Schwarz – VP Marketing
O: 203-969-2700 C: 201-665-0899
E: jschwarz@proximityhealthsolutions.com
W: www.ProximityHealthSolutions.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
